Summit Therapeutics Inc’s recently made public that its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Summit Therapeutics
In a filing, Summit Therapeutics Inc revealed its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Summit Therapeutics
Summit Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Summit Therapeutics
In a filing, Summit Therapeutics Inc revealed its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Summit Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million